TLSI Q1 2025 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9M+42.0% YoY

Gross Profit

$8M83.7% margin

Operating Income

-$7M-79.9% margin

Net Income

-$10M-113.2% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+11.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$29M

Total Liabilities

$63M

Stockholders' Equity

-$34M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$6M	+42.0%
Gross Profit	$8M	$5M	+39.8%
Operating Income	-$7M	-$12M	+37.3%
Net Income	-$10M	-$13M	+21.5%